Literature DB >> 12202155

Human peripheral blood monocyte-derived interleukin-10-induced semi-mature dendritic cells induce anergic CD4(+) and CD8(+) T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fragments.

Katsuaki Sato1, Naohide Yamashita, Takami Matsuyama.   

Abstract

We examined the ability of human monocyte-derived interleukin (IL)-10-induced semi-mature dendritic cells (semi-mDCs) that had been pulsed with soluble protein and necrotic cellular fragments to induce an antigen (Ag)-specific anergy in CD4(+) and CD8(+) T cells. IL-10 converted normal immature DCs (iDCs) into semi-mDCs during the maturation. In contrast to normal iDCs and mature DCs, IL-10-induced semi-mDCs as well as IL-10-treated iDCs not only had reduced their allogeneic T cell-stimulatory capacity, but also induced an allogeneic Ag-specific anergy in T cells. Normal mDCs that had been pulsed with tetanus toxin (TT) or allogeneic necrotic cellular fragments caused further activation of TT-specific CD4(+) T cells or allogeneic fibroblast-specific CD8(+) T cells, Ag-pulsed IL-10-induced semi-mDCs induced an anergic state in both cell types. Thus, our results suggest that IL-10-induced semi-mDCs induce an Ag-specific anergy in CD4(+) and CD8(+) T cells via presentation of the internalized protein and cross-presentation of the phagocytosed cellular fragments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202155     DOI: 10.1016/s0008-8749(02)00021-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  17 in total

1.  Cytokine-conditioned dendritic cells induce humoral tolerance to protein therapy in mice.

Authors:  Gautam Sule; Masataka Suzuki; Kilian Guse; Racel Cela; John R Rodgers; Brendan Lee
Journal:  Hum Gene Ther       Date:  2012-05-11       Impact factor: 5.695

2.  Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

Authors:  Alejo Chorny; Elena Gonzalez-Rey; Amelia Fernandez-Martin; David Pozo; Doina Ganea; Mario Delgado
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

3.  Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

Authors:  Elena Gonzalez-Rey; Alejo Chorny; Amelia Fernandez-Martin; Doina Ganea; Mario Delgado
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

Review 4.  Dendritic cell control of tolerogenic responses.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

5.  Dendritic cells modification during sublingual immunotherapy in children with allergic symptoms to house dust mites.

Authors:  Federica Angelini; Valentina Pacciani; Stefania Corrente; Romina Silenzi; Alessandra Di Pede; Antonella Polito; Carla Riccardi; Silvia Di Cesare; Marie Laure Yammine; Paolo Rossi; Viviana Moschese; Loredana Chini
Journal:  World J Pediatr       Date:  2010-12-30       Impact factor: 2.764

6.  Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?

Authors:  Arno Hanninen; Leonard C Harrison
Journal:  Rev Diabet Stud       Date:  2004-11-10

7.  Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection.

Authors:  N Hyodo; I Nakamura; M Imawari
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

8.  Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance.

Authors:  Angus W Thomson; Hēth R Turnquist; Alan F Zahorchak; Giorgio Raimondi
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

9.  Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells.

Authors:  A W Pedersen; K Holmstrøm; S S Jensen; D Fuchs; S Rasmussen; P Kvistborg; M H Claesson; M-B Zocca
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

10.  The induction of APC with a distinct tolerogenic phenotype via contact-dependent STAT3 activation.

Authors:  Devorah Gur-Wahnon; Zipora Borovsky; Meir Liebergall; Jacob Rachmilewitz
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.